Nicolas Borkmann
Chairman at Omega Navigation Enterprises, Inc.
Net worth: 898 770 $ as of 2024-05-30
Network origin in Nicolas Borkmann first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Omega Navigation Enterprises, Inc.
 Omega Navigation Enterprises, Inc. Marine ShippingTransportation Omega Navigation Enterprises, Inc. operates as an investment holding company, which engages in the provision of marine transportation services through the ownership and operation of double hull product tankers. It focuses on seaborne transportation of refined petroleum products. The firm also provides technical, operating and administrative services to the joint venture companies. The company was founded on February 28, 2005 and is headquartered in Athens, Greece.
5
| Private Company | Marine Shipping | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Nicolas Borkmann via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Rochester Christian University | College/University | Graduate Degree | |
| Baytown Navigation, Inc. | Corporate Secretary | ||
| Beaumont Navigation, Inc. | Corporate Secretary | ||
| Carrolton Navigation, Inc. | Corporate Secretary | ||
| Decatur Navigation, Inc. | Corporate Secretary | ||
| Elgin Navigation, Inc. | Corporate Secretary | ||
| Fulton Navigation, Inc. | Corporate Secretary | ||
| Galveston Navigation, Inc. | Corporate Secretary | ||
| Omega Navigation USA LLC | Corporate Secretary | ||
| Orange Navigation, Inc. | Corporate Secretary | ||
| ABU DHABI COMMERCIAL BANK | Major Banks | Private Equity Investor | |
| University of Salford | College/University | Undergraduate Degree | |
| The University of Southampton | College/University | Graduate Degree | |
| Fairfield University | College/University | Undergraduate Degree | |
| University of London | College/University | Graduate Degree | |
| New York University | College/University | Masters Business Admin | |
| Pace University | College/University | Masters Business Admin | |
| Rider University | College/University | Undergraduate Degree | |
| Federal Reserve Bank of New York | General Government | Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Undergraduate Degree | |
| Aristotle University of Thessaloniki | College/University | Graduate Degree | |
| OMAN INTERNATIONAL DEVELOPMENT AND INVESTMENT COMPANY SAOG | Investment Managers | President | |
The International Society for Optical Engineering
 The International Society for Optical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Optical Engineering operates as society for optics and photonics. It advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth. The company was founded on July 1, 1955 and is headquartered in Bellingham, WA. | Miscellaneous Commercial Services | President | |
Injaz Mena investment Co. (Private Equity)
 Injaz Mena investment Co. (Private Equity) Investment ManagersFinance Injaz Mena Investment Co (Private Equity) (Injaz Mena Investment) is a private equity subsidiary of Injaz Mena Investment Co PSC founded in 2005. The firm is headquartered in Abu Dhabi, UAE. | Investment Managers | Director/Board Member | |
| Pareefers KS | Director/Board Member | ||
| Sextant Consultancy Ltd. | Director/Board Member | ||
Shoreline Mutual (Bermuda) Ltd.
 Shoreline Mutual (Bermuda) Ltd. Insurance Brokers/ServicesFinance Shoreline Mutual (Bermuda) Ltd. provides insurance services. The private company is based in Hamilton, Bermuda. | Insurance Brokers/Services | Director/Board Member | |
Ervaxx Ltd.
 Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Pharmaceuticals: Major | Founder |
Statistics
International
| United States | 18 |
| United Kingdom | 6 |
| United Arab Emirates | 3 |
| France | 2 |
| Greece | 2 |
Sectoral
| Consumer Services | 11 |
| Finance | 7 |
| Government | 2 |
| Commercial Services | 2 |
| Health Technology | 2 |
Operational
| Corporate Secretary | 10 |
| Director/Board Member | 8 |
| Undergraduate Degree | 4 |
| Graduate Degree | 4 |
| President | 3 |
Most connected contacts
- Stock Market
- Insiders
- Nicolas Borkmann
- Company connections
